Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential cation channel subfamily C member 4 (TRPC4) is a non-selective, calcium-permeable cation channel involved in various physiological processes. It is activated by Gαi-coupled receptors, Gαq-coupled receptors, and tyrosine kinases, playing roles in endothelial permeability, vasodilation, neurotransmitter release, and cell proliferation. TRPC4 is highly expressed in cortico-limbic regions of the brain and endothelial cells. Its dysregulation is implicated in several diseases, including pulmonary hypertension, cardiac hypertrophy and seizure susceptibility. The channel is regulated by endogenous proteins such as calmodulin and can be modulated by small molecule inhibitors like GFB compounds.
Inhibition of TRPC4 channel activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily C member 4 (TRPC4).